Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Uleri V"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Valeria Uleri, Anna Cutarelli, Pellegrino Cerino, Sante Roperto, Adriana Florinela Cătoi, Ivan Gentile, Francesca De Falco
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
Frontiers in Immunology
Persistent infection and tumourigenesis by papillomaviruses (PVs) require viral manipulation of various of cellular processes, including those involved in innate immune responses. Herein, we showed that bovine PV (BPV) E5 oncoprotein interacts with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f547f646ae5410616c711ac57fafedb7
https://doi.org/10.3389/fimmu.2021.658762
https://doi.org/10.3389/fimmu.2021.658762
Autor:
Radhakrishnan D; Faculty of Science, University of Ostrava, 30. dubna 22, 701 03 Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 17. listopadu 1790, 708 52 Ostrava, Czech Republic., Kotulová J; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 17. listopadu 1790, 708 52 Ostrava, Czech Republic., Hofmanová L; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 17. listopadu 1790, 708 52 Ostrava, Czech Republic., Sithara AA; Faculty of Science, University of Ostrava, 30. dubna 22, 701 03 Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 17. listopadu 1790, 708 52 Ostrava, Czech Republic., Turi M; Faculty of Science, University of Ostrava, 30. dubna 22, 701 03 Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 17. listopadu 1790, 708 52 Ostrava, Czech Republic.; Candiolo Cancer Institute, FPO-IRCCS, Strada Provinciale, 142-KM 3.95-, 10060 Candiolo (TO), Italy., Žihala D; Faculty of Science, University of Ostrava, 30. dubna 22, 701 03 Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 17. listopadu 1790, 708 52 Ostrava, Czech Republic., Ďurech M; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 17. listopadu 1790, 708 52 Ostrava, Czech Republic., Vrána J; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 17. listopadu 1790, 708 52 Ostrava, Czech Republic., Uleri V; Laboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, 142 20 Praha, Czech Republic., Niederlova V; Laboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, 142 20 Praha, Czech Republic.; Department of Cell Biology, Faculty of Science, Charles University in Prague, Albertov 6, Prague 4, 128 20 Czech Republic., Stepanek O; Laboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, 142 20 Praha, Czech Republic., Chyra Z; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 17. listopadu 1790, 708 52 Ostrava, Czech Republic., Jelínek T; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 17. listopadu 1790, 708 52 Ostrava, Czech Republic., Hájek R; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 17. listopadu 1790, 708 52 Ostrava, Czech Republic., Hrdinka M; Faculty of Science, University of Ostrava, 30. dubna 22, 701 03 Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 17. listopadu 1790, 708 52 Ostrava, Czech Republic.
Publikováno v:
Journal of leukocyte biology [J Leukoc Biol] 2024 Dec 31; Vol. 117 (1).